Trial Profile
A phase IV study to evaluate the effectiveness of FluMist (influenza vaccine; live intranasal) vaccination in a school-based intervention program
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2008
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Sep 2008 Actual end date (Apr 2005) added as reported by ClinicalTrials.gov.
- 31 Oct 2005 New trial record.